Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Year-over-year operating income growth rate
Latest
-98.30%
↓ 1123% vs avg
Percentile
P5
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
-8.04%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -98.30% |
| Q3 2025 | 218.98% |
| Q2 2025 | -4.49% |
| Q1 2025 | 280.74% |
| Q4 2024 | -85.90% |
| Q3 2024 | 29.77% |
| Q2 2024 | -59.58% |
| Q1 2024 | 108.81% |
| Q4 2023 | -817.89% |
| Q3 2023 | 156.61% |
| Q2 2023 | -25.36% |
| Q1 2023 | 44.82% |
| Q4 2022 | 0.00% |
| Q3 2022 | 180.52% |
| Q2 2022 | 61.13% |
| Q1 2022 | 27.63% |
| Q4 2021 | 19.49% |
| Q3 2021 | -26.69% |
| Q2 2021 | 11.25% |
| Q1 2021 | -19.09% |
| Q4 2020 | -17.02% |
| Q3 2020 | 7.26% |
| Q2 2020 | -242.56% |
| Q1 2020 | 63.77% |
| Q4 2019 | -6.00% |
| Q3 2019 | 8.25% |
| Q2 2019 | 8.48% |
| Q1 2019 | -34.49% |
| Q4 2018 | -40.01% |
| Q3 2018 | -17.30% |
| Q2 2018 | -6.51% |
| Q1 2018 | -14.58% |
| Q4 2017 | 0.83% |
| Q3 2017 | 1.11% |
| Q2 2017 | -42.51% |
| Q1 2017 | 20.10% |
| Q4 2016 | 8.61% |
| Q3 2016 | -16.22% |
| Q2 2016 | -7.50% |
| Q1 2016 | 2.39% |